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Abstract
Over the past three decades, a public health crisis, the opioid epidemic, has ravaged the lives of
individuals, families, as well as entire communities across the US. The prevalence and
complexities of substance use disorder (SUD) and opioid use disorder (OUD) continue to
challenge clinicians to find effective treatment options for clients. The focus of this literature is
to develop support for using art therapy (AT) as a form of treatment for those with SUD, to
distinguish the benefits that community-based AT could provide, and propose the need for
further research that explores the use of community-based AT with those with SUD. The
literature was drawn from areas of inquiry such as art therapy, neurobiology, substance use
disorder, and community-based art therapy. The research has shown that art therapy provides
numerous benefits for those with SUD as well as communities. Art therapy offers an alternative
form of expressive communication that can enable personal growth and healing. The literature
identifies that the benefits that art therapy provides match many of the unique needs of the SUD
population. Additionally, research has shown that art therapy positively affects similar
neuropathways that are negatively impacted by prolonged substance use. This research
demonstrates that art therapy is a useful form of treatment that could counteract the negative
neurological effects of SUD.

Keywords: art therapy, community-based art therapy, substance use disorder, opioid use
disorder, opioid epidemic, gap in the research
Author Statement: The author identifies as a white, cisgender female of mixed European ancestry
from rural New England.

2
Introduction
Over the past three decades, the United States has seen the devastating effects of the
opioid epidemic, a public health crisis that has swept across the nation. The current opioid
epidemic has affected the lives of individuals, families, and communities across the US (Sharma,
Bruner, Barnett, & Fishman, 2016). The opioid epidemic has caused suffering and death across
the country, from large metropolitan areas to small rural communities (American Society of
Addiction Medicine, n.d.; National Institute on Drug Abuse, 2019; Noonan, 2017; Scholl et al.,
2018; Van Zee, 2009).
Research indicates that art therapy (AT) has been used in the treatment of substance use
disorders (SUD) in many clinical treatment settings for more than six decades (Feen-Calligan et
al., 2008; Holt & Kaiser, 2009; Schmanke, 2017). The literature also indicates that the use of AT
with this population has been shown to be beneficial in ways that traditional talk therapy
sometimes is unable to. Some of these benefits include helping to promote self-expression,
nurturing creativity, encouraging creative problem solving, providing aesthetic distance,
providing a safe means of engaging in self-reflection and providing more profound insight,
supporting a form of nonverbal communication, and developing a supportive community of
peers (Casey & Webb, 2019; Halužan, 2012; Olsen & Sharfstein, 2019). The literature provides
additional evidence that engaging in community-based art therapy provides a means of building
community; unites the group to work towards a common cause; provides a useful technique to
process the thoughts and emotions tied to a shared experience; provides a means of telling the
story of an issue, group, or community. Community-based art therapy may also allow the
community to reclaim their identity; serve as an avenue for confronting stigmas, stereotypes, and
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discrimination; and it serves as a tool for facilitating social change; among other benefits
(Berman, 2017; Klorer, 2014; Milbrandt, 2010).
While the use of AT in some treatment centers is not uncommon, there is no literature
that discusses the use of AT with individuals in recovery from SUD outside of a clinical
treatment setting, including community-based settings. Furthermore, there is no literature that
has explored the use of community-based AT in response to the current opioid epidemic. This
indicates a gap in the literature regarding the use of AT with this population in community-based
settings, as well as the use of art therapy with those who have been affected by the ongoing
opioid epidemic.
This thesis was initially intended to be a community engagement project. However, as the
final preparations were being made to start the project, it was shut down by the emergence of the
worldwide coronavirus pandemic. Because conducting the project was rendered impossible, this
thesis became a literature review. The first section of the literature review will provide a detailed
examination of the historical origins of the crisis as well as what contributing factors led to the
current opioid epidemic. The next section will investigate SUD. The following section will
explore the neurological effects of SUD. The next section will provide a brief overview of AT,
and then explore how AT has been used in the treatment of SUD and its benefits for this
population. The following section will explore the use and benefits of AT in community-based
settings. Next, the neurological effects of AT will be presented, followed by the proposal for the
need for further research on the potential benefits of community-based AT for individuals in
recovery and those affected by the opioid epidemic.
My thesis will stress the need to provide multimodal supportive resources that maintain
the continuation of treatment for those in recovery beyond their allotted time in clinical treatment
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programs. Furthermore, the current research will argue for the importance of involving the
community in addressing the opioid epidemic. Additionally, the research will demonstrate how
the use of AT can help those in recovery from SUD and be used as a vehicle for creating
meaningful social change. The importance of this work has only increased due to the current
coronavirus pandemic, which has seen a significant increase in overdoses and subsequent deaths
due to isolation, lack of access to treatment centers and recovery meetings, and the stress and
depression that this pandemic has brought about (Kamp & Campo-Flores, 2020; Mann, 2020;
Weiner, 2020).
Method
Research for this literature was collected using the Lesley University online database to
find peer reviewed scholarly articles using search terms including art therapy, community-based
art therapy, substance use disorder, art therapy in the treatment of substance use disorder,
communities affected by the opioid epidemic, history of the opioid epidemic, and art therapy and
the opioid epidemic. Other research was conducted using google search engine to find relevant
news articles and information that discussed the opioid epidemic, its history, and political factors
that contributed to the epidemic. The data was organized chronologically and by subject. These
subjects comprised of the history of the opioid epidemic; current events concerning the opioid
epidemic; neurobiological effects of substance use and art therapy; art therapy and substance use
disorder; art therapy use in clinical substance use disorder treatment; and community-based art
therapy. Articles and other data were organized and stored into the appropriate subject folder.
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Literature Review
This literature review begins with an exploration of the history of the opioid epidemic
from the Civil War to 1970. Next, the history from the War on Drugs to the present time was
investigated. The following section briefly discussed SUD, then the neurobiological effects of
SUD and art therapy was explored. The next section provided a brief overview of art therapy.
Next the use of AT as a treatment method for SUD in clinical settings as well as the use of AT in
community-based settings was investigated. The literature concludes with the discussion section.
History of the Opioid Epidemic: Civil War to 1970
The current opioid epidemic has had a remarkable effect on communities across the
entire nation. But how, when, and why did this crisis start? To understand how the current
opioid epidemic came to be, it is essential to investigate the historical origins that led up to this
crisis. Opioids have been used as a treatment for pain for centuries (Bernard et al., 2018;
Buchman et al., 2017; Jones et al., 2018; Olsen & Sharfstein, 2019; Rummans et al., 2018).
Opioids such as opium and heroin, as well as other highly addictive substances such as cocaine,
were once readily available to the public and found in many over-the-counter treatments for
everyday afflictions such as menstrual cramps, toothaches, and indigestion (Buchman et al.,
2017; Jones et al., 2018; Olsen & Sharfstein, 2019). The use of these substances was quite
common during the nineteenth and twentieth centuries, not only for their medicinal use but also
for recreational use. The recreational use of these substances was seen as a simple personal vice,
much like alcohol or cigarettes (Buchman et al., 2017; Olsen & Sharfstein, 2019). It was not until
much later that the highly addictive nature of these substances and the deadly consequences of
their continued use were fully realized.
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Morphine was one of the early opioid pain treatments that were used medically during a
pinnacle event in US history (Bernard et al., 2018; Buchman et al., 2017; Olsen & Sharfstein,
2019). Morphine was used to treat soldiers and civilians that were injured during the American
Civil War, one of the country’s most prolific wars (Bernard et al., 2018; Buchman et al., 2017;
Olsen & Sharfstein, 2019; Unick et al., 2013). The medical benefits of morphine were profound,
as its therapeutic use provided relief from debilitating pain for injuries suffered by many soldiers
and civilians (Bernard et al., 2018; Olsen & Sharfstein, 2019; Rummans et al., 2018). However,
after the war had ended, numerous individuals who were treated with morphine during the war
still relied on these narcotics. The continued use of these opioids led many of those who were
treated with them to develop a dependence on opioids and subsequently develop higher levels of
tolerance. The increase in individuals’ tolerance of opioid doses led to a higher demand for
opioids with increased potency. (Bernard et al., 2018; Buchman et al., 2017; Olsen & Sharfstein,
2019; Rummans et al., 2018).
During the nineteenth century, opioids were available with many over-the-counter
treatments and through prescriptions. Many white individuals from middle- and uppersocioeconomic statuses used these treatments both medically and recreationally (Buchman et al.,
2017; Olsen & Sharfstein, 2019). The individuals who would use these narcotics habitually
would eventually become dependent on these narcotics, which would later be known as opioid
use disorder (OUD). Everyday citizens faced the same problematic opioid use disorders as the
civil war soldiers who were given morphine during and after the war years (Buchman et al.,
2017; Olsen & Sharfstein, 2019).
As time progressed into the early 20th century, there was a significant increase in the
number of individuals who had developed substance use disorders (Buchman et al., 2017; Olsen
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& Sharfstein, 2019). These narcotics' non-medicinal and medicinal use crossed both racial,
ethnic, cultural, and socioeconomic lines (Buchman et al., 2017; Olsen & Sharfstein, 2019;
Rummans et al., 2018). Even though narcotics were used by many groups of people, when these
narcotics became criminalized, these substances and the use of these narcotics became
stigmatized and unjustly associated with racial and ethnic minorities and other oppressed and
marginalized groups (Buchman et al., 2017; Olsen & Sharfstein, 2019; Rummans et al., 2018).
These marginalized groups were discriminated against because they were viewed as lower-class
citizens by the dominant white, Christian, middle to upper-class society (Buchman et al., 2017;
Olsen & Sharfstein, 2019; Rummans et al., 2018).
Issues created by using these narcotics were only acknowledged as a public health issue
after the number of white, Christian, working-class individuals who developed opioid use
disorders could no longer be ignored. It was at this point that both medical and legislative action
was taken to try and mitigate this problem (Buchman et al., 2017; Olsen & Sharfstein, 2019).
The steps taken to try and control the public health issue led to the development, passing, and
implementation of the 1914 Harrison Narcotic Control Act (HNCA). According to Olsen &
Sharfstein (2019), “the 1914 Harrison Act not only turned many users into criminals, but it also
forbade physicians from prescribing the most effective form of treatment” (p. 154). This act
designated that the consequences for prescribing opioids in a manner deemed irresponsible could
result in a physician losing their medical license or serving jail time (Buchman et al., 2017,
Jones, et al., 2018; Olsen & Sharfstein., 2019). As a result, the general public’s attitude towards
opioids in medicinal and non-medicinal use was drastically changed. According to Olsen &
Sharfstein (2019), “in the early 20th century, when drug use became illegal across the United
States and much of the world, people who used drugs became criminals incarcerated rather than
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cared for” (p. 15). The use of opioids went from being seen as a “personal vice” to criminal
activity (Barry et al., 2014; Buchman et al., 2017; Olsen & Sharfstein, 2019). Following this act,
both patients and physicians alike began to avoid prescribing or using opioids to treat medical
conditions. The medical prohibition of opioids continued throughout most of the 20th century
(Buchman et al., 2017; Olsen & Sharfstein, 2019).
History of Opioid Epidemic: The War on Drugs to Present
In 1971, then-President Richard Nixon declared his War on Drugs initiative in response
to the rise of the drug counterculture and protests the war in Vietnam that arose throughout the
1960s and 1970s (Olsen & Sharfstein, 2019). This initiative created a new department of law
enforcement that was charged to manage what was considered the escalating drug problem in the
US. This new department was named the Drug Enforcement Agency (DEA). The DEA
department was created because of this initiative, which placed the DEA operatives as crucial
players in the United States’ domestic drug policy (Buchman et al., 2017; Olsen & Sharfstein,
2019). The War on Drugs, as well as the HNCA, worked to criminalize those who used opioids
and other substances as well as the manufacturers of these illegal substances (Olsen &
Sharfstein, 2019). However, no action was taken to focus on helping those who struggled with
substance use (i.e., providing effective treatment options for those who used these opioids either
illicitly or prescribed). However, it is imperative to note that prescribed opioids are just as
addictive as illicit opioids, which have and continue to be misused just like illicit opioids
(Buchman et al., 2017; Olsen & Sharfstein, 2019).
The 1914 HNCA, the 1956 Narcotic Control Act, Nixon’s War on Drugs in 1971,
Reagan’s Anti-Drug Abuse Act in 1986, which included mandatory minimum sentences for drug
possession, Clinton’s crime bill of 1994, as well as Trump’s racist and xenophobic propaganda
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blaming individuals from Mexico for the importation of drugs into the US and his promise of a
“border wall” to create a barrier on the US/Mexico border, have all helped to fuel the mass
incarceration of people from marginalized groups for nonviolent drug offenses (Olsen &
Sharfstein, 2019). These marginalized groups continue to be disproportionately targeted by these
policies, which were created because of the aforenoted initiatives (Bernard et al., 2018; Buchman
et al., 2017; Jones et al, 2018; Lyapustina & Alexander, 2015; Olsen & Sharfstein, 2019). The
targeting and stigmatizing of these oppressed and marginalized groups demonstrate how stigmas
associated with substance use were initiated by narratives created by the dominant white
supremacist society (Olsen & Sharfstein, 2019). Even though these narratives were created long
ago, they continue to prevail in our current society (Bernard et al., 2018; Buchman et al., 2017;
Olsen & Sharfstein, 2019).
Prior to the late 20th century, opioids were generally reserved only for the treatment of
severe traumatic pain, end of life care, and pain related to the treatment of cancer (Bernard et al.,
2018; Brand, 2018; Buchman et al., 2017; Jones et al., 2018; Olsen & Sharfstein, 2019;
Rummans et al., 2018; Van Zee, 2009) This began to change when the prohibition of opioids
began to shift during the 1980s. Much of the research regarding the history of the current opioid
epidemic cite a specific source that was cited frequently and used as a significant influencing
factor behind this change. This source is a short, one-paragraph letter entitled, “Addiction Rare
in Patients Treated with Narcotics,” written by Jane Porter and Boston University professor
Hershel Jick (1980). This letter was published on January 10th, 1980, in the popular medical
journal The New England Journal of Medicine (Bernard, et al, 2018; Buchman et al., 2017;
Jones, et al, 2018; Olsen & Sharfstein, 2019; Porter & Jick, 1989; Rummans, et al., 2018; Van
Zee, 2009). The Porter and Jick (1980) letter stated that out of 11,882 hospitalized patients who
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were treated over a short term, under medical supervision, with opioid narcotics for acute pain,
only four had developed an opioid use disorder (Bernard, et al, 2018; Buchman et al., 2017;
Jones, et al, 2018; Rummans et al., 2018; Van Zee, 2009). This letter did not provide further
evidence that the use of opioids over an extended period for chronic pain and/or non-cancerrelated pain was either safe or effective (Bernard et al., 2018; Buchman et al., 2017; Jones et al.,
2018; Olsen & Sharfstein, 2019; Rummans et al., 2018). Despite this, the letter became a widely
used resource to support the long-term use of opioids for chronic pain. Since the Porter & Jick
(1980) letter was published, it has been cited more than 600 times to support the crusade which
promoted the long-term use of opioids for treating chronic pain (Buchman et al., 2017; Olsen &
Sharfstein, 2019; Rummans et al., 2018). According to Olsen & Sharfstein (2019), “Hershel Jick
would later state that he was ‘mortified’ about his letter’s legacy, as his research related to
hospitalized patients, not patients with chronic pain” (p. 137). This further exemplifies how this
letter, and its research were taken out of context and touted as evidence to support the cause of
this crusade.
Many advocates, scientists, and special interest groups campaigned for the long-term use
of opioids in the treatment of chronic, non-cancer-related pain (Buchman et al., 2017; Olsen &
Sharfstein, 2019; Rummans et al., 2018). These groups often used invalid sources such as the
Porter and Jick (1980) letter, as well as other such sources to support their claims that pain was
undertreated, and their promotion of less restricted use of opioids in the management of chronic
and non-cancer related pain (Bernard et al., 2018; Buchman et al., 2017; Jones et al., 2018;
Mularski et al., 2006; Olsen & Sharfstein, 2019; Rummans et al., 2017).
This crusade was further promoted by The American Pain Society (APS) which began its
campaign in 1995 declaring that pain need to be viewed and treated similarly to vital signs. This
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campaign indicated that pain was drastically undertreated and needed to be evaluated and
managed by clinicians in a similar manner to the way that they evaluate and manage a patient’s
vital signs (Bernard, et al, 2018; Buchman et al., 2017; Lyapustina & Alexander, 2015; Mularski
et al., 2006; Olsen & Sharfstein, 2019; Rummans et al., 2018). This campaign was supported by
the Veteran’s Health Administration (VHA) who in 1998 introduced a form of documentation
where hospital patients would designate their level of pain on a scale from 0-to 10. This initiative
became known as the ‘Pain as the 5th vital sign’ (Bernard et al., 2018; Buchman et al., 2017;
Lyapustina & Alexander, 2015; Mularski et al., 2006; Olsen & Sharfstein, 2019; Rummans et al.,
2018). This initiative led the Center for Medicare and Medicaid Services (CMS) and the Agency
for Healthcare Research and Quality to create a 25-question survey entitled the Hospital
Consumer of Healthcare Providers and Systems (HCAHPS) (Bernard et al., 2018; Olsen &
Sharfstein, 2019; Rummans et al., 2018). The HCAHPS survey included information about
patient's reported level of satisfaction regarding the care they received while in the hospital
(Bernard et al., 2018; Buchman et al., 2017; Jones et al., 2018; Olsen & Sharfstein, 2019;
Rummans et al., 2018). This survey became a representation of a hospital’s quality of care given
to patients. The surveys were required to be submitted or the hospital would incur a penalty fine
(Bernard et al., 2018; Jones et al., 2018; Olsen & Sharfstein, 2019; Rummans et al., 2018). A
hospital’s overall survey score would be used to determine if and how much federal healthcare
funding a hospital would receive. Out of the 25 questions on this survey, three were designated
to a patient's reported level of satisfaction regarding the treatment of their pain management. The
patient satisfaction section of the survey made up 30% of the overall score. As a result, clinicians
were pushed to either prescribe more opiates to appease patients or risk losing their funding and
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incurring a fine (Bernard et al., 2018; Buchman et al., 2017; Jones et al., 2018; Lyapustina &
Alexander, 2015; Olsen & Sharfstein, 2019; Rummans et al., 2018).
As a result of the campaigns that advocated for the use of opioids for chronic and noncancer related pain, the number of opioids being prescribed in the US began to greatly increase
(Bernard et al., 2018; Buchman et al., 2017; Jones et al., 2018; Lyapustina & Alexander, 2015;
Olsen & Sharfstein, 2019; Rummans et al., 2018). According to Olsen & Sharfstein (2019) “the
cultural change in prescribing opioids for pain touched every corner of medical practice - from
cardiology to neurology, from dentistry to emergency medicine, from nurse practitioners to
physician assistants, from surgery to primary care” (p. 144). The number of opiate prescriptions
increased dramatically not only because of these initiatives, but also because of aggressive
marketing done by big pharmaceutical corporations, specifically, Purdue Pharmaceutical
(Bernard et al., 2018; Buchman et al., 2018; Olsen & Sharfstein, 2019). In 1995 Purdue
Pharmaceuticals developed and released the extended-release opiate medication OxyContin® on
the market (Bernard et al., 2018; Buchman et al., 2017; Jones et al., 2018; Lyapustina &
Alexander, 2015; Olsen & Sharfstein, 2019; Rummans et al., 2018). Purdue Pharmaceuticals
used sources lacking sufficient scientific evidence, such as the Porter and Jick (1980) letter, to
promote the use of their medication for long-term chronic pain. Purdue created advertisements
that stated that opioids, specifically their opioid medication OxyContin®, were safe for treating
chronic and non-cancer related pain over an extended period and it was less addictive than
traditional opioid medications (Bernard et al., 2018; Buchman et al., 2017; Olsen & Sharfstein,
2019; Rummans et al., 2018).
Purdue additionally sent physicians and hospitals across the nation a training video called
“OxyContin® Got My Life Back” which deceptively identified OxyContin® as a safe
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medication and detailed that this medication was formulated in a way that addiction was much
less likely to occur (Bernard et al., 2018; Buchman et al., 2017; Jones et al., 2018; Olsen &
Sharfstein, 2019; Rummans et al., 2018). Purdue also exceedingly used data out of context to
support their claims about the safety of the use of their product. These claims and misuse of data
were all used successfully to reassure doctors and the public about the safety of using
OxyContin® as a long-term treatment method (Bernard et al., 2018; Buchman et al., 2017; Jones
et al., 2018; Olsen & Sharfstein, 2019; Rummans et al., 2018). The efforts of the crusade in
supporting the use of opioids for chronic pain as well as the aggressive marketing performed by
Purdue Pharmaceuticals were successful and proved to be profitable for the company (Bernard et
al., 2018; Buchman et al., 2017; Olsen & Sharfstein, 2019). By the year 2016, the United States
had 62 million people prescribed at least one form of opioid medication, and the US was
consuming 80% of the world’s prescription opioids (Olsen & Sharfstein, 2019; Rummans et al.,
2018).
In 2004, Purdue was arraigned by the West Virginia attorney general for downplaying
the dangers of addiction to their product OxyContin®, which the company settled the case for 10
million dollars. In 2007 Purdue Pharmaceuticals was taken to court by the US Department of
Justice, pled guilty to criminal charges and fined 6 hundred million dollars for knowingly
advertising their product with deceptive information which downplayed the addictiveness of
their product (Bernard et al., 2018; Buchman et al., 2017; Jones et al., 2018; Olsen & Sharfstein,
2019; Rummans et al., 2018). The lies and misdirection of Purdue Pharmaceuticals had finally
been revealed after over a decade of deceit. Despite the charges and fines that Purdue
Pharmaceutical incurred, the damage was already done. The United States is amid a full-blown
opioid epidemic (Bernard et al., 2018; Olsen & Sharfstein, 2019; Rummans et al., 2018).
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The opioid epidemic has had a severe and disturbing impact on countless communities
and families throughout the US including in the state of Massachusetts. In the year 2019 alone,
the state of Massachusetts had over 1,500 confirmed deaths resulting from opioid-related
overdoses (Massachusetts Department of Public Health, 2019a, 2019b, 2020). In the same year,
Massachusetts was listed as one of the top ten states in the nation with the highest number of
deaths resulting from opioid-related overdoses (National Institute on Drug Abuse, 2019). The
reluctance of the US government to formally address this crisis earlier is believed to have
contributed to the widespread impact of this epidemic which did not just affect large
metropolitan cities but also suburban and rural communities (Olsen & Sharfstein, 2019).
Between the years of 1999 and 2017, over 700,000 people died of drug overdoses in the
United States. Over 56% or nearly 400,000 of these deaths were confirmed to be from opioid
related overdoses (Jones, et al., 2018; Rummans et al., 2018; Scholl, et al., 2018). In the year
2017, 1,913 people died of confirmed opioid related overdoses in Massachusetts (Jones, et al.,
2018; National Institute on Drug Abuse, 2019). In October of 2017, the United States
Government officially acknowledged the opioid epidemic as a public health emergency
(Bernard, et al., 2018; Buchman et al., 2017; Jones, et al, 2018; Olsen & Sharfstein, 2019). The
history of the use of opioids in the United States has shown that this is not the first time that this
country has dealt with an opioid epidemic. In fact, the events of the past epidemics are uncannily
like the events the country is facing today with the current opioid epidemic (Bernard et al., 2018;
Buchman et al., 2017; Olsen & Sharfstein, 2019). The current opioid epidemic is the result of
multiple contributing factors that for over a century have created the appropriate circumstances
which permitted this crisis to grow and eventually spread across the nation (Bernard et al., 2018;
Buchman et al., 2017; Jones, et al, 2018; Olsen & Sharfstein, 2019; Rummans et al., 2018).
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Substance Use Disorder/Opioid Use Disorder
SUDs are characterized by an obsessive craving for substances and both impulsive and
compulsive behaviors that compel someone to continue using a substance or substances despite
negative consequences (Buchman et al., 2017; Olsen & Sharfstein, 2019; Volkow et al., 2016;
Volkow & Morales, 2015). People with SUD continue to use a substance despite the often severe
negative consequences that can impact their health, relationships, and day to day life (Buchman
et al., 2017; Olsen & Sharfstein, 2019; Volkow et al., 2016; Volkow & Morales, 2015). The
worst of these consequences is of course death (Matto, 2002; Megranahan & Lynskey, 2018;
Olsen & Sharfstein, 2019; Volkow et al., 2016). For those suffering from OUD, the substance
that is causing these severe cravings and compulsions is opioids. Both prescription and illicit
opioids can be addictive and can be extremely dangerous. (Bernard et al., 2018; Buchman et al.,
2017; Olsen & Sharfstein, 2019; Rummans et al., 2017).
SUD, which includes OUD, is a largely misunderstood medical condition (Olsen &
Sharfstein, 2019; Volkow et al., 2016). Those who suffer from SUD/ OUD are often referred to
as ‘addicts’ (Barry et al., 2014; Jones et al., 2018; Olsen & Sharfstein, 2019; Schmanke, 2017).
Research has shown that there is a significant stigma associated with this label as well as other
commonly used labels that are often placed upon those suffering from these disorders. The
common use of labels such as these is shown to have caused widespread discrimination and bias
against those suffering from SUD. This discrimination only further impacts their already difficult
recovery journeys (Bernard et al., 2018; Buchman et al., 2017; Olsen & Sharfstein, 2019;
Rummans et al., 2018).
The discrimination and bias against those with SUD inhibit their access to jobs, their
access to safe housing, and contribute greatly to the lack of social support that is needed during
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this difficult and vulnerable period of their lives (Barry et al., 2014; Matto, 2002; Megranahan et
al., 2018; Olsen & Sharfstein, 2019). It is understandable that the discrimination and lack of
access to essential needs and supports would only intensify any feelings of anger, inferiority,
guilt, shame, remorse, and hopelessness that those struggling with SUD/OUD often suffer from
(Buchman et al., 2017; Olsen & Sharfstein, 2019; Rummans et al., 2017; Schmanke, 2017;
Skeffington & Browne, 2014). These negative emotions coupled with lacking access to the
necessary support and basic needs often make the already difficult recovery journey even harder
and would likely severely deter these individuals' ability to continue with their recovery journeys
(Buchman et al., 2017; Matto, 2002; Olsen & Sharfstein, 2019; Rummans et al., 2018).
Treating SUD, the same way as other medical disorders, is important for reducing the
stigma surrounding it (Barry et al., 2014; Buchman et al., 2017; Olsen & Sharfstein, 2019;
Rummans et al., 2018; Volkow et al., 2016). According to the American Society of Addiction
Medicine (ASAM), addiction is “a treatable, chronic medical disease involving complex
interactions among brain circuits, genetics, the environment, and an individual’s life experiences.
People with addiction use substances or engage in behaviors that become compulsive and often
continue despite harmful consequences” (2019). This definition provides an example of how
addiction is seen and understood through the lens of the medical model. This helps to clarify that
SUD is a medical disease. By identifying SUD as a real disease, ASAM is addressing some of
the associated stigmas and misconceptions that are often associated with SUD/OUD (Jones et al.,
2018; Olsen & Sharfstein, 2019; Schmanke, 2017; Skeffington & Browne, 2014).
SUD can be influenced by numerous bio-psycho-social factors including an individual’s
familial genetics, direct or indirect exposure to traumatic events, a lack of access to affordable
mental health treatment, as well as environments where they grew up, and geography (Buchman
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et al., 2017; Olsen & Sharfstein, 2019; Schmanke, 2017; Skeffington & Browne, 2014).
Definitions such as the one provided by the ASAM, help to clarify that SUDs are not a choice
and are not the result of having a weak moral compass (Olsen & Sharfstein, 2019; Skeffington &
Browne, 2014; Volkow et al., 2016; Volkow & Morales, 2015). Using this definition helps
confront stigma because it specifies that this disorder is a medical condition that should be
regarded and treated the same way as any other medical condition (Barry et al., 2014; Buchman
et al., 2017; Olsen & Sharfstein, 2019).
According to the National Institute on Drug Abuse (NIDA), “addiction is a lot like other
diseases, such as heart disease. Both disrupt normal, healthy functioning… have serious harmful
effects, that in many cases, are preventable and treatable…can last a lifetime and… lead to
death” (2020). While many consider SUD to be a choice or a result of moral failure, they fail to
recognize the bio-psycho-social aspects of SUD and its neurological effects (Olsen & Sharfstein,
2019; Schmanke, 2017; Skeffington & Browne, 2014; Volkow et al., 2016; Volkow & Morales,
2015).
Neurobiological effects of SUD
Volkow et al. (2016) identified that SUD affects the brain of those who struggle with this
disorder. The authors explained that SUD critically manipulates an individual’s way of thinking,
behaviors, and ability to control specific actions such as impulses (Matto, 2002; Olsen &
Sharfstein, 2019; Schmanke, 2017; Volkow & Morales, 2015). Volkow et al. (2016) asserted that
addictive substances, such as opioids, stimulate the brain’s reward center by releasing intense
dopamine surges. When the brain’s reward center is stimulated after recurrent occurrences, the
brain learns to associate the sense of reward with those specific stimuli, which can include
people, places, objects, and sensory-related stimuli (Olsen & Sharfstein, 2019; Volkow et al.,
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2016). When these external stimuli have become associated with the sense of reward, dopamine
begins to be released by experiencing the associated stimuli. The dopamine is being released as
an anticipatory response to the stimuli instead of for the reward. These releases of dopamine in
response to stimuli are what create triggers and subsequent cravings for individuals with SUD
(Matto, 2002; Olsen & Sharfstein, 2019; Schmanke, 2017; Volkow et al., 2016).
These conditioned responses become profoundly embedded and can cause the individual
to experience cravings even after the person has stopped using the substance long ago.
According to Volkow & Morales (2015) repeated substance use “triggers neuroplastic changes in
the glutamatergic inputs to the striatum and midbrain dopamine neurons, enhancing the brain’s
reactivity to drug cues, reducing the sensitivity to non-drug rewards, weakening self-regulation,
and increasing the sensitivity to stressful stimuli and dysphoria” (p. 712). Therefore, as stated by
Volkow & Morales (2015) “interventions designed to counteract dysphoria or strengthen
executive control… may improve long-term success and recovery from addiction” (p. 720). Art
therapy research has shown that AT counteracts dysphoria and can strengthen the executive
control functioning in the brain that is affected by prolonged SUD, which makes it an ideal
treatment option for supporting those in recovery from SUD (Schmanke, 2017).
Treatment of SUD
According to Olsen & Sharfstein (2019), there are several components involved in the
effective treatment of SUD/OUD. These components include medication, mental health
counseling, and social support. Research indicates that a multimodal approach to SUD treatment,
which includes therapy, is the most effective treatment method (Matto, 2002; Olsen &
Sharfstein, 2019; Schmanke, 2017; Volkow et al, 2016; Volkow & Morales, 2015). Medication
is often involved when treating individuals with OUD. Olsen & Sharfstein (2019) have identified
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that the United States Food and Drug Administration (FDA) has approved the following
medications for OUD treatment: buprenorphine, methadone, and naltrexone. These medications
have been tested and shown to effectively help reduce illicit opioid use by satiating the parts of
the brain that cue cravings for substances while also inhibiting the sensation of pleasure and
reward related to the substance use (Olsen & Sharfstein, 2019). Over time, these medications
help to reduce cravings. By gradually diminishing cravings, these medications also help to
reduce the actions or behaviors that an individual would engage in to obtain the substances
(Olsen & Sharfstein, 2019; Volkow et al., 2016).
Along with medication, psychotherapy is a vital part of SUD treatment (Olsen &
Sharfstein, 2019). A major objective of SUD counseling is supporting people to learn how to
identify their triggers and how to effectively react to them (Olsen & Sharfstein, 2019; Schmanke,
2017). Counseling can reveal underlying psychological features and needed supportive social
services, which may be contributing to the SUD. With this knowledge, counselors can provide
better support and resources to those they serve, as they can help them learn how to manage their
SUD as well as any other contributing bio-psycho-social factors (Matto, 2002; Olsen &
Sharfstein, 2019; Schmanke, 2017; Skeffington & Browne, 2014). It is also important to screen
clients with SUD/OUD for other underlying conditions, as they may be using substances to selfmedicate. A few of the other conditions that are often diagnosed in individuals suffering from
SUD include depression, bipolar disorder, and post-traumatic stress disorder (PTSD) (Olsen &
Sharfstein, 2019). According to Olsen & Sharfstein (2019), “all people with addiction need
social support, including healthy friendships and access to nutritious food, safe housing, and, for
many people, employment” (p. 18). Without access to these important social supports, those with
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SUD would likely find maintaining their recovery incredibly difficult, if not impossible (Barry et
al., 2014; Buchman et al., 2017; Olsen & Sharfstein, 2019).
Art Therapy
Art therapy (AT) is a form of psychotherapy that utilizes the creative process of
artmaking to facilitate therapeutic growth, healing, and transformation. As a therapeutic
modality, AT goes beyond traditional talk therapy by incorporating the cognitive and physical
processes involved in creating artwork to expand on what can be expressed through verbal
communication alone (Feen-Calligan et al., 2008; Malchiodi, 2011; Schmanke, 2017). AT is a
practice that exercises the creative process as a means of expressing emotions and thoughts in a
manner that facilitates reparation, insight, motivation, and recovery (Feen-Calligan et al., 2008;
Hanes, 2017; Malchiodi, 2011; Schmanke, 2017). AT is a creative therapeutic modality that is
shown to be beneficial for people of all ages. Using the therapeutic creative process, clients can
gain insight, create meaning in their lives, express and find relief from difficult and traumatic
experiences, express and clarify overpowering and unconscious emotions, enhance overall sense
of wellbeing, and improve ones’ everyday life (Malchiodi, 2011).
Art Therapy in the Treatment of SUD
The first mention of art therapy being used as a treatment modality for individuals with
SUD was in an article featured in the psychiatric journal Psychiatry in the early 1950s (FeenCalligan, 2007; Hanes, 2017; Schmanke, 2017). The 1953 article was authored by art therapy
pioneer Elinor Ulman. In the article, Ulman elaborated on her time working at the Alcoholic
Rehabilitation Program of the District of Columbia (Schmanke, 2017). The first article which
described the use of art therapy with the SUD population was written nearly 70 years ago; since
then, several studies and literature that explores art therapy as a treatment modality with this
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population has been published (Feen-Calligan, 2007; Laurer & Van der Vennet, 2015;
Megranahan & Lynskey, 2018; Schmanke, 2017). Of these studies that have been done, art
therapy has been shown to be highly useful in treating those with SUD (Adedoyin et al., 2014;
Feen-Calligan et al., 2008; Horay, 2006; Schmanke, 2017).
The literature will focus on three of the benefits that art therapy provides for those in
recovery. The first of these benefits is the use of art therapy as a form of nonverbal, expressive,
and symbolic communication (Hanes, 2017; Holt & Kaiser, 2009; Schmanke, 2017). Hanes’s
(2017) conducted a qualitative study with women in a residential substance use treatment facility
which discovered that the client’s road drawing artwork served as a metaphor for their potential
and motivation for change. Another study conducted by Holt & Kaiser (2009) explored the use
of an art therapy protocol involving five directives with clients in the early stages of SUD
treatment. This research found that the creative process helped clients to express conscious and
uncover unconscious feelings, thoughts, and experiences. Revealing these feelings, thoughts, and
experiences allowed for the examination of both known and previously unknown information
yielding for implicit knowledge to convert into explicit knowledge. The authors further identified
that self-expression provided clients with a subsequent sense of emotional relief.
The second benefit art therapy can offer those in recovery is a valuable method to
identify, explore, and process difficult emotions, thoughts, and experiences through the creative
process (Feen-Calligan et al., 2008; Hanes, 2017; Schmanke, 2017; Skeffington & Browne,
2014). A qualitative study conducted by Feen-Calligan et al. (2008) investigated the effects of
using famous art reproductions in group therapy with minority women in residential inpatient
SUD treatment facilities. This study established that clients were able to find links between their
thoughts, feelings, and behaviors, plus recognize the effect that these attitudes and perceptions
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had on their recovery process. The researchers discovered that clients were able to interpret and
relate to the mood conveyed from the artwork. By relating to the art on an emotional level, the
artwork provided a platform that allowed the clients to feel safe disclosing about difficult
experiences, including traumatic experiences, that they associated with the feeling expressed in
the artwork. A case study with a female client in an Australian substance use treatment facility
conducted by Skeffington & Browne (2014) found that artwork produced in group art therapy
sessions provided a meaningful opportunity for the client to safely face and explore their past
traumatic experiences in a way that was not overwhelming. Additionally, this case study found
that addressing these experiences in this way also helped to facilitate therapeutic transformation
for the client that awakened their internal motivation to change their maladaptive lifestyle.
The third benefit art therapy provides for those in recovery is a process that allows for
enhanced self-awareness, an opportunity to gain insight, explore possible options, identify needs,
and acknowledge the need to change (Feen-Calligan et al., 2008; Hanes, 2017; Schmanke, 2017;
Skeffington & Browne, 2014). A review conducted by Adedoyin et al., (2014) explored whether
expressive therapy interventions improved the efficacy of conventional outpatient substance use
treatment approaches. Through their research, the authors found evidence that “art therapy can
facilitate new insights, expression of emotions and conflicts, and formulating new perspectives
that encourage positive growth and healing” (p. 542). The authors elaborated that art therapy is a
holistic process that utilizes all the senses and provides clients an opportunity to separate
themselves from their troubles, via the creative process. This in turn offers a meaningful way for
the clients to gain an objective perception of the issue. With this newfound perception, clients
along with their therapist, can uncover useful solutions for the troubles they are facing (Feen-
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Calligan et al., 2008; Hanes, 2017; Kapitan et al., 2011; Matto, 2002; Schmanke, 2017;
Skeffington & Browne, 2014).
Community Art Therapy
Art therapy is a practice that is not strictly limited to private or clinical treatment settings.
Other sites where AT is used include community-based settings (Kapitan et al., 2011; Potash &
Vance, 2022; Slayton, 2012; Talwar, 2015). Community-based AT uses healing or
transformative arts interventions focused on organizational and community needs versus
interventions designed to meet individual clients or group needs within clinical or private
practice settings (Kapitan et al., 2011; Slayton, 2012). It is typical for community-based AT to
form cooperative affiliations with organizations based in the community that identifies social
advocacy as a primary objective (Kapitan et al., 2011; Nolan, 2019; Slayton, 2012).
Research has shown that community-based art therapy can provide many advantages
(Golub, 2005; Nolan, 2019; Potash & Vance, 2022; Slayton, 2012). For the purposes of this
literature review, two of the advantages that meet the needs of those with SUD will be
investigated. The first advantage that will be explored is how community-based art therapy helps
to bring people together to build a community of healing and work towards a common goal
(Nolan, 2019; Potash & Vance, 2022; Slayton, 2012). The second advantage is how communitybased art therapy can empower a community to work together to create social change (Golub,
2005; Nolan, 2019; Potash & Vance, 2022; Slayton, 2012).
The first advantage of bringing a community together to heal and work towards a
common goal is demonstrated in a qualitative study conducted by DelliCarpini (2020). The
author facilitated a community-based mural making project in New York City with youths
involved in the city’s justice system. The study’s objective was to boost social connection and
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facilitate “social power shifts within a collective community” (p. 185). The study revealed that
the participants were able to enhance their communal connections, and through the mural project
found a creative and meaningful way to critique the misrepresentation that is imposed on them
by a dominant society that actively rejects their sense of agency.
The second benefit is how community-based art therapy can be used to empower a
community and create social change. This advantage is demonstrated in a qualitative thematic
analysis conducted by Potash & Vance (2022). This analysis investigated protest artwork
displayed during a Black Lives Matter protest at the White House in response to the murder of
George Floyd by police (Egan et al., 2020). Potash & Vance’s analysis results found that the
artwork signage and the protest itself “offered a collective vision for social change and building
cross-racial solidarity” (p. 126). The authors found that the artwork served to identify and
communicate systemic problems, upheld and celebrated Black cultural identity, communicated
the dignity of the Black community in their resistance against oppression, and the artwork served
to memorialize those who had been killed. Kapitan et al. (2011) supports this evidence by
indicating that “a traumatized community may turn to the arts to helps its members move from
personal tragedy towards shared experiences that restore collective identity” (p. 65). Potash &
Vance (2022) additionally discovered that the protestors’ artwork contained both explicit
messages asserting the need for social change as well as serving as a container for holding and
sharing the complex emotions held by the protestors and a significant portion of the US
population (Potash & Vance, 2022).
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Discussion
Art therapy in specific clinical settings devoted to SUD treatment within the US has been
practiced since at least the 1950s. Despite the significant history of the use of art therapy in
clinical SUD treatment, there is no literature is available that investigates the use of art therapy in
community-based treatment settings as a form of ongoing treatment option for those with SUD.
The lack of research that explores the use of art therapy outside of clinical settings for those with
SUD illustrates a major gap in the present art therapy literature. This gap is particularly relevant
as it demonstrates the lack of available ongoing community-based treatment options (Olsen &
Sharfstein, 2019) that utilize the healing power of the arts for those individuals and communities
that have and continue to be affected by the current opioid epidemic.
Community-based AT for those with SUD can provide vital community and social
support for those in recovery (Kapitan et al., 2011; Potash & Vance, 2022; Talwar, 2015). After
completing a clinical treatment program, those in recovery are often sent home. For many of
those in recovery, their home communities are the same communities where they were active in
their substance use before treatment. By returning to the same environments, those in recovery
are essentially being forced to face unavoidable triggers that induce powerful cravings alone
while they are still very vulnerable in the early stages of their recovery process (Olsen &
Sharfstein, 2019; Schmanke, 2017). This places those in recovery in situations that could
endanger their recovery as well as their lives. When those in recovery come across the same
places and people that they historically associate with their substance use, they may be triggered
and once again experience cravings (Matto, 2002; Olsen & Sharfstein, 2019; Volkow et al.,
2016). Although they may have abstained from substance use throughout their time in clinical
treatment and possibly beyond, cravings pose a threat to anyone in recovery, regardless of how
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long it’s been since they last used. This is especially true when there is a lack of available
resources where they can access the type of support that they need (Olsen & Sharfstein, 2019).
While the strategies and skills that they developed while in treatment may help to some
degree, with repeated exposure to triggers, the likelihood that they may relapse increases (Matto,
2002; Olsen & Sharfstein, 2019; Schmanke, 2017; Skeffington & Browne, 2014; Volkow et al.,
2016; Volkow & Morales, 2015). Financial instability is an issue that often affects those with
SUD/OUD (Olsen & Sharfstein, 2019; Schmanke, 2017; Skeffington & Browne, 2014). Because
of this, most people in recovery don’t have the ability to just move to a new community and start
a whole new life. Since most people do not have this type of privilege, those in recovery may
feel stuck in an environment where they are faced with unavoidable people, places, and things
that trigger cravings which further compounds the difficult recovery journey (Matto, 2002; Olsen
& Sharfstein, 2019; Schmanke, 2017; Skeffington & Browne, 2014; Volkow et al., 2016;
Volkow & Morales, 2015). This is especially relevant for those who live in communities that
have been extensively affected by the current opioid epidemic (Olsen & Sharfstein, 2019).
Without access to appropriate community-based AT programs that provide the support
that those in recovery need in their day to day lives, the likelihood of relapse, overdose, and
death is significantly increased (Casey & Webb, 2019; Kapitan et al., 2011; Matto, 2002; Olsen
& Sharfstein, 2019; Volkow et al., 2016). While specific resources such as Alcoholics
Anonymous (AA) and Narcotics Anonymous (NA) meetings are generally available, they may
not necessarily be appropriate or provide the support needed for everyone in recovery. Not
everyone in recovery finds that AA or NA meetings are helpful to their circumstance, and there
is no one-size-fits-all treatment for SUD (Dickson, 2007; Hanes, 2017; Olsen & Sharfstein,
2019; Schmanke, 2017). The literature maintains that multimodal approaches to SUD treatment
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are the most effective (Olsen & Sharfstein, 2019; Schmanke, 2017; Skeffington & Browne,
2014; Volkow et al., 2016; Volkow & Morales, 2015). Therefore, providing alternative resources
such as community-based AT programs for those in SUD recovery could provide invaluable
support to not only individuals in recovery but also to the wider communities affected by the
opioid epidemic (Casey & Webb, 2019; Kapitan et al., 2011; Klorer, 2014; Olsen & Sharfstein,
2019).
The current opioid epidemic has had a devastating effect on individuals, families, and
communities across the US. While some clinical treatment options are available for individuals
with SUD/OUD that utilize AT within their programs, supportive community-based treatment
options that use art therapy outside of clinical SUD treatment settings, are scarce to non-existent.
Literature discussing the use of AT with those with SUD in clinical settings has shown that it can
be a highly beneficial form of treatment for this population (Feen- Calligan, 2007; Feen- Caligan
et al., 2008; Hanes, 2017; Holt & Kaiser, 2009; Skeffington & Browne, 2014). Due to the
advantages that art therapy can provide for this population within clinical settings, it can be
assumed that art therapy would also be beneficial as a form of ongoing treatment. This treatment
option would be particularly valuable to those who have completed inpatient clinical treatment
programs and those who do not have access to clinical treatment options. Furthermore,
community-based therapeutic interventions could provide a more extensive scale resource to
whole communities affected by the opioid epidemic (Olsen & Sharfstein, 2019). Based on the
research that identifies the many benefits that art therapy provides those within treatment for
SUD, it is surmisable that community-based art therapy interventions would be especially
valuable for communities confronting the devastating effects of the opioid epidemic.
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Due to the current COVID-19 pandemic, I could not pursue the community engagement
project that I had initially planned to do. However, it is my goal that my research will illuminate
this gap within the art therapy literature and illustrate the need for further investigation. I also
hope that my research may provide a stepping-off point for future studies in examining the
possible benefits of using community-based art therapy with both individuals and communities
struggling with or affected by SUD/OUD. The ongoing opioid epidemic has increased the need
for diverse treatment options, as well as treatment providers available to those within
communities who are affected by OUD (Olsen & Sharfstein, 2019; Volkow et al., 2016).
Community-based art therapy has the potential to provide a valuable resource for both the
individuals and communities affected by this epidemic. This type of resource could prove useful
to those who have found that they cannot access traditional clinical treatment resources or the
available services within their community are lacking the type of support they need (Olsen &
Sharfstein, 2019). Community-based art therapy can provide an accessible, supportive, and
healing form of treatment to those in need, especially those who are struggling to maintain their
recovery after completing their clinical treatment program (Hanes, 2017; Kapitan et al., 2011;
Schmanke, 2019; Skeffington & Browne, 2014).
Limitations for this review include the small number of participants involved in the
studies. Because of this the results for any of the research cannot be generalized. Not all the
research used concluded that AT would be the most beneficial treatment modality to use with the
SUD population. Research conducted by Megranahan et al. (2018) identified music therapy to be
the most beneficial modality to use with this population. The literature used was all English
language articles which limits the scope of this review. Much of the research was conducted in
clinical inpatient SUD treatment settings in the US which is not accessible for many
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marginalized communities. Lastly, I recognize that my worldview has been shaped by my
heritage, culture, privilege, environment, relationships, and education which influences the
perspective and possible bias of this review. Unfortunately, there is no literature available that
discusses the use of community-based AT with those in recovery from SUD, or as a response to
the effects of the opioid epidemic. As mentioned earlier, the need for community-based supports
and resources plays an important role in helping those with SUD/OUD to maintain their recovery
(Olsen & Sharfstein, 2019; Schmanke, 2017; Volkow et al., 2016). Having treatment resources
that utilize AT in community-based settings would fill a much-needed gap in the available
treatment options to individuals in recovery and provide a valuable resource for the wider
community effected by the opioid epidemic.
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